# A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Source: https://onco.cc/trials/nct04300556/  
OnCo record `nct04300556` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Prednisone, Dexamethasone and Lenvatinib in advanced solid tumours, run by Eisai Inc., now recruiting.

## Summary

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types is a phase 1/2 interventional study registered as NCT04300556 by Eisai Inc., with 182 participants planned, started 2020-08-06 and due to reach its primary completion in 2030-08-08. Interventions recorded: Farletuzumab ecteribulin, Prednisone, Prednisolone, Dexamethasone and Lenvatinib.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT04300556
- Phase: 1/2
- Setting: A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Subjects With Selected Tumor Types
- Sponsor: Eisai Inc.
- Enrolled: 182

## Sources

- ClinicalTrials.gov NCT04300556: https://clinicaltrials.gov/study/NCT04300556

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Dexamethasone](https://onco.cc/drugs/dexamethasone/), [Farletuzumab ecteribulin](https://onco.cc/drugs/farletuzumab-ecteribulin/), [Lenvatinib](https://onco.cc/drugs/lenvatinib/), [Prednisone](https://onco.cc/drugs/prednisone/)
- companies: [Eisai](https://onco.cc/companies/eisai/)

---
JSON: https://onco.cc/api/v1/entities/nct04300556.json